Skip to main content

Advertisement

Improving QoL for bipolar patients: treatment of different and complex phases of illness

Article metrics

  • 1174 Accesses

Until recently, most systematic studies in bipolar disorder concentrated on reduction of illness severity as the primary outcome measure. However, functional disabilities even in euthymic phases are a key issue [1] and improving quality of life in different domains as work, family and social activities appears to be of utmost importance for patients as a recent WHO survey shows. Especially in bipolar depression, functionality of patients appears severely impaired throughout several domains [2]. As demonstrated by Hirschfeld et al. [3] this impairment appears more severe in bipolar compared to unipolar depression. Thus, not only reducing depressive symptomatology but also improving quality of life should be a primary target for any new treatment option, both pharmacological and non-pharmacological. Psychotherapy, even just psychoeducation, can clearly improve coping with the illness and by this also improve quality of life [4]. In addition, some new pharmacological treatment options as the atypical antipsychotic quetiapine could demonstrate that they are not only improving depressive symptomatology in bipolar depression, but also significantly improve quality of life as measured with the Q-LES-Q (Quality of Life Enjoyment and Satisfaction Questionnaire: 16-item short form [5]).

Measuring quality of life as a important outcome parameter in controlled studies may contribute to make those studies and new medications also more meaningful for patients.

References

  1. 1.

    Coryell W, Scheftner W, Keller M, Endicott J, Maser J, Klerman GL: The enduring psychosocial consequences of mania and depression. Am J Psychiatry. 1993, 150: 720-727.

  2. 2.

    Calabrese JR, Hirschfeld RM, Frye MA, Reed ML: Impact of depressive symptoms compared with manic symptoms in bipolar disorder: results of a U.S. community-based sample. J Clin Psychiatry. 2004, 65: 1499-1504.

  3. 3.

    Hirschfeld RM: Bipolar depression: the real challenge. Eur Neuropsychopharmacol. 2004, 14 (Suppl 2): S83-S88. 10.1016/j.euroneuro.2004.03.001.

  4. 4.

    Michalak EE, Yatham LN, Wan DD, Lam RW: Perceived quality of life in patients with bipolar disorder. Does group psychoeducation have an impact?. Can J Psychiatry. 2005, 50: 95-100.

  5. 5.

    Endicott J, Nee J, Harrison W, Blumenthal R: Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull. 1993, 29: 321-326.

Download references

Author information

Correspondence to Heinz Grunze.

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Grunze, H. Improving QoL for bipolar patients: treatment of different and complex phases of illness. Ann Gen Psychiatry 5, S41 (2006) doi:10.1186/1744-859X-5-S1-S41

Download citation

Keywords

  • Bipolar Disorder
  • Quetiapine
  • Primary Outcome Measure
  • Short Form
  • Outcome Parameter